A secondary analysis of a multicentre trial explores which patient profiles may show greater vulnerability during programmed frozen embryo transfer cycles.

The study uses multicentre trial data to identify phenotypes associated with different outcomes after frozen embryo transfer. The aim is to understand patient heterogeneity rather than establish a definitive clinical risk classification.

What it means for practice

Such analyses may guide future research into maternal characteristics linked to complications. Independent validation is needed before any routine clinical use.

Source: Frontiers in Medicine